Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0590
-0.0014
(-2.32%)
At close: February 21 at 3:29:01 PM GMT+1
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Thomas Skovlund Schnegelsberg | CEO, Co-Founder & Member of Executive Board | -- | -- | 1965 |
| Mr. Rolf Steno Petersen | Co-Founder, Chief Commercial Officer & Director | -- | -- | 1965 |
| Mr. Soren Kjaer | Co-Founder & COO | -- | -- | 1964 |
| Mr. Peter Bugge Johansen | Chief Financial Officer | -- | -- | 1962 |
Stenocare A/S
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products to patients in the Danish and European markets. It offers medical cannabis oil products. Stenocare A/S was incorporated in 2017 and is based in Randers, Denmark.
Corporate Governance
Stenocare A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available